National Comprehensive Cancer Network
- NCCN Guidelines™ &
Clinical Resources- NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines™)
- NCCN Drugs & Biologics Compendium (NCCN Compendium™)
- NCCN Chemotherapy Order Templates (NCCN Templates™)
- NCCN Mobile Applications
- NCCN International Resources
- NCCN Flash Updates™
- On-line Catalog
- JNCCN – The Journal of the National Comprehensive Cancer Network
- NCCN Disclosure Policies & Potential Conflicts of Interest
- Educational Events & Programs
- NCCN Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™
- NCCN Annual Congress: Hematologic Malignancies™
- NCCN 2010 Congress Series™
- NCCN Webinar: Treatment Strategies for Mesothelioma
- NCCN Guidelines Update Webinar Series™
- NCCN Academy for Excellence & Leadership in Oncology™
- NCCN Insights™: Analytics, Consulting & Research Capabilities Webinar
- NCCN Patient Safety Summit
- NCCN On-line CME/CE
- NCCN Oncology Case Management Program™
- NCCN International Programs
About NCCN
Hodgkin Disease/Lymphoma Panel - Disclosures as of 9/2/2010
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Ranjana H. Advani, MD |
Allos |
Allos |
None |
None |
11/30/2009 |
Weiyun Z. Ai, MD |
None |
None |
None |
None |
7/23/2009 |
Richard F. Ambinder, MD, PhD |
None |
None |
None |
None |
12/16/2009 |
Celeste M. Bello, MD, MSPH |
None |
Spectrum Pharmaceuticals |
None |
None |
1/11/2010 |
Philip J. Bierman, MD |
Bradmer Pharmaceuticals |
None |
None |
None |
9/18/2009 |
Kristie A. Blum, MD |
None |
None |
None |
None |
7/1/2009 |
Bouthaina Dabaja, MD |
None |
None |
None |
None |
7/6/2009 |
Ysabel Duron |
None |
None |
None |
None |
1/13/2010 |
Andrew M. Evens, DO, MS |
None |
None |
None |
None |
7/1/2009 |
Andres Forero, MD |
Biogen Idec; |
None |
None |
None |
9/28/2009 |
Lauren Gallagher, RPh, PhD |
None |
None |
None |
None |
8/23/2010 |
Leo I. Gordon, MD |
CureTech Ltd.; |
CureTech Ltd. |
None |
CureTech Ltd. |
7/21/2009 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
8/30/2010 |
Francisco Hernandez-Ilizaliturri, MD |
None |
Amgen Inc. |
None |
None |
6/11/2010 |
Ephraim P. Hochberg, MD |
None |
Amgen Inc.; |
None |
None |
7/22/2009 |
Richard T. Hoppe, MD |
None |
None |
None |
None |
7/22/2009 |
Melissa M. Hudson, MD |
None |
None |
None |
None |
7/3/2009 |
David G. Maloney, MD, PhD |
None |
Celgene Corporation; |
None |
None |
11/30/2009 |
David Mansur, MD |
None |
None |
None |
None |
7/10/2009 |
Peter Mauch, MD |
None |
None |
None |
None |
11/20/2009 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/18/2010 |
Joseph O. Moore, MD |
Genentech, Inc.; |
Amgen Inc.; |
None |
None |
10/28/2009 |
David Morgan, MD |
None |
None |
None |
None |
10/6/2009 |
Craig H. Moskowitz, MD |
Cephalon, Inc.; |
Seattle Genetics |
None |
None |
7/1/2009 |
Russell J. Schilder, MD |
None |
None |
None |
None |
7/2/2009 |
Hema Sundar, PhD |
None |
None |
None |
Cephalon, Inc. |
7/19/2010 |
Lawrence Weiss, MD |
None |
Clarient, Inc |
None |
None |
11/23/2009 |
Jane N. Winter, MD |
Genentech, Inc. |
Novartis Pharmaceuticals Corporation |
None |
None |
12/23/2009 |
Joachim Yahalom, MD |
None |
None |
None |
None |
11/20/2009 |
Privacy Policy| Legal Notices| Site Map| Contact Us| Help
Copyright © 2010 National Comprehensive Cancer Network, All Rights Reserved